Clinical trial
Comparison of Hypoglycaemic Response Between NN1250 and Insulin Glargine in Type 1 Diabetics
NCT01002768
Study timeline
Study start (unknown)2009-10-01Date precision: month
Registry last updated2017-01-20
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Diabetesunresolved
Diabetes Mellitus, Type 1unresolved
Interventions
insulin degludecDRUG · verified · RxNorm: insulin degludec
insulin glargineDRUG · verified · RxNorm: insulin glargine
Sponsors & collaborators
Novo Nordisk A/Slead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01002768 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.